Summary & Overview

HCPCS J0738: Lenacapavir Injection for HIV Pre-Exposure Prophylaxis

HCPCS Level II code J0738 designates the 1 mg injection of lenacapavir when prescribed and administered for HIV pre-exposure prophylaxis (PrEP). As a newly codified injectable PrEP agent, this code matters nationally because it enables discrete billing for a long-acting preventive medication distinct from treatment regimens, affecting access, coverage determinations, and payer policy alignment across commercial and public plans. Key payers in scope include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.

Readers will learn what J0738 represents clinically and operationally, which payers are relevant for coverage considerations, and what to look for in administrative workflows for PrEP delivery. The publication summarizes benchmarks and payer coverage themes, highlights clinical context for a long-acting injectable PrEP option, and outlines common coding and billing elements associated with administration in outpatient and clinic settings. Data not available in the input will be noted where applicable. This overview is written for a national audience and focuses on the code’s role in payment and service delivery for HIV prevention.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicareJ0738HCPCS Level IIlenacapavirHIV PrEPinjectable PrEPmedication administrationoutpatient clinicpharmacy billing

Billing Code Overview

HCPCS Level II code J0738 represents the injection formulation of lenacapavir, 1 mg, specifically indicated as an FDA-approved prescription for HIV pre-exposure prophylaxis (PrEP) and explicitly not for use as treatment for HIV. The code covers administration of the injectable antiretroviral product when used for PrEP.

Service type: Medication administration of a long-acting antiretroviral agent for HIV prevention
Typical site of service: Outpatient infusion or clinic-based injection setting, including specialty clinics and community-based PrEP programs

Clinical & Coding Specifications

Clinical Context

A 30-year-old cisgender man presents to an outpatient HIV prevention clinic seeking pre-exposure prophylaxis (PrEP) after reporting sexual exposure to partners with unknown HIV status and inconsistent condom use. Baseline evaluation includes HIV antigen/antibody testing, renal function, hepatitis B and C screening, and risk assessment. The clinician determines lenacapavir injectable PrEP is appropriate per eligibility criteria. The patient receives an initial subcutaneous or intramuscular administration of J0738 (lenacapavir) in the clinic. The clinic documents informed consent, verifies no active HIV infection, records lot number and expiration of the drug, and observes the patient for immediate adverse reactions for the standard monitoring period. Follow-up visits include interval HIV testing, assessment of adherence and side effects, and subsequent maintenance dosing per FDA-approved schedule. Typical sites of service are outpatient ambulatory clinics, community health centers, sexual health clinics, and federally qualified health centers. Billing occurs for the drug using J0738 with any applicable modifiers to reflect payer requirements, administration circumstances, or special payment situations.

Coding Specifications

Modifier	Description	When to Use
`00`	No modifier; standard claim submission	Use when no special circumstances apply and the injection is billed as usual.
`22`	Increased procedural services	Use when substantially greater work is required for administration (e.g., complex access or extended counseling) with appropriate documentation.
`23`	Unusual anesthesia	Use if unusual anesthesia is required for the injection procedure.
`52`	Reduced services	Use when the full service is not performed as originally planned.
`53`	Discontinued procedure	Use when the administration was started but discontinued due to patient condition.
`55`	Postoperative management only	Rare for this code; use if only post-procedure management is billed and applicable under payer rules.
`62`	Two surgeons	Use if two providers of different specialties are involved in a manner recognized by payer policy (rare for injection codes).
`78`	Unplanned return to operating/procedure room	Use if patient returns unexpectedly for procedure-related complication management.
`80`	Assistant surgeon	Use if an assistant surgeon is applicable and allowed by payer (uncommon for injections).
`82`	Assistant surgeon when qualified resident not available	Use per payer policy if applicable.

Taxonomy Code	Specialty	Notes
`163W00000X`	Infectious Disease	Specialty commonly managing PrEP selection and follow-up.
`207Q00000X`	Family Medicine	Primary care clinicians frequently initiate and maintain PrEP.
`207R00000X`	Internal Medicine	Internists managing chronic prevention and monitoring.
`363LP0800X`	Nurse Practitioner	NPs often administer injections and coordinate PrEP care.
`163WP0800X`	HIV/AIDS Specialist	Providers focused on comprehensive HIV prevention services.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`Z20.6`	Contact with and (suspected) exposure to HIV	Indicates exposure risk prompting consideration of PrEP.
`Z72.51`	High-risk heterosexual behavior	Documents behavioral risk relevant to PrEP candidacy.
`Z72.52`	High-risk homosexual behavior	Documents MSM risk behaviors often associated with PrEP use.
`Z11.4`	Encounter for screening for human immunodeficiency virus [HIV]	Used for screening encounters before initiation and during follow-up.
`Z71.7`	Human immunodeficiency virus [HIV] counseling	Used when counseling is provided as part of PrEP services.
`Z00.00`	Encounter for general adult medical examination without abnormal findings	Used for preventive visits where PrEP may be discussed/initiated.
`R79.89`	Other specified abnormal findings of blood chemistry	May be used for abnormal lab monitoring results that influence PrEP management.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`96372`	Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular	Commonly used for billing the administration service when separate from the drug acquisition code `J0738`.
`36415`	Collection of venous blood by venipuncture	Performed for baseline and follow-up HIV and laboratory monitoring related to PrEP.
`87807`	Infectious agent antigen detection by immunoassay with direct optical observation; HIV-1/2 antigen/antibody	Used for point-of-care or laboratory HIV testing prior to and during PrEP.
`99401`	Preventive medicine counseling or risk-reduction intervention(s) (15 minutes)	Counseling and risk-reduction services associated with initiating PrEP and adherence support.
`99213`	Office or other outpatient visit for the evaluation and management of an established patient, low to moderate complexity	Typical E/M visit code for follow-up assessments and documentation when combined with injection services.